The Personalized Medicine and Cell Therapy market was valued at USD 7.92 Billion in 2024 and is expected to reach USD 21.72 Billion by 2032, growing at a CAGR of 13.44% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.